HCPCS Code G0567

Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique

Procedures/Professional Services (Temporary Codes)

G0567 is a valid 2026 HCPCS code for Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique or just “Screening hep c detect” for short, used in Diagnostic laboratory.

HCPCS Code Details - G0567

HCPCS Level II Code
Procedures/Professional Services (Temporary Codes)
HCPCS Code G0567
Description

Long description:
Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique

Short description:
Screening hep c detect

HCPCS Modifier1
HCPCS Pricing indicator 13 - Clinical Lab Fee Schedule - Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code T1H - Lab tests - other (non-Medicare fee schedule)
HCPCS Action code N - No maintenance for this code
Type of service 5 - Diagnostic laboratory
Effective date Effective Jun 27, 2024
Date added Added Jun 27, 2024
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
“NU” identifies the hospital bed as new equipment

See also

  • HCPCS G0566 · 3d radiodensity-value bone imaging, algorithm derived, from previous magnetic resonance examination of the same anatomy

  • HCPCS G0476 · Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test

  • HCPCS U0003 · Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

  • HCPCS U0005 · Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2

  • HCPCS G0568 · Initial psychiatric collaborative care management, in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional, initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan, review by the psychiatric consultant with modifications of the plan if recommended, entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant, and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies (list separately in addition to the advanced primary care management code)

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”